Article Information
- Received June 15, 2016
- Revision received July 29, 2016
- Accepted July 29, 2016
- Published online August 3, 2016.
Author Information
- Tristan D. McClure-Begley1,2,3,
- Irina Esterlis1,
- Kathryn L. Stone4,
- TuKiet T. Lam4,5,
- Sharon R. Grady2,
- Christopher M. Colangelo4,5,
- Jon M. Lindstrom6,
- Michael J. Marks2,7 and
- Marina R. Picciotto1,4
- 1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508
- 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80303
- 3Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309
- 4W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, Connecticut 06509
- 5Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, Connecticut 06520
- 6Department of Neuroscience, Medical School of the University of Pennsylvania, Philadelphia, Pennsylvania 19104
- 7Department of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309
- Correspondence should be addressed to Marina R. Picciotto, Department of Psychiatry, Yale University School of Medicine, 34 Park Street, 3rd Floor Research, New Haven, CT 06508. E-mail: marina.picciotto{at}yale.edu.
Author contributions
Author contributions: T.D.M.-B., M.J.M., and M.R.P. designed research; T.D.M.-B., K.L.S., T.T.L., S.R.G., C.M.C., and M.J.M. performed research; I.E. and J.M.L. contributed unpublished reagents/analytic tools; T.D.M.-B., K.L.S., T.T.L., and C.M.C. analyzed data; T.D.M.-B. and M.R.P. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This research was funded by Grants MH-077681 and DA-14241 (to M.R.P.), K01-MH-092681 (to I.E.), DA-018343 (National Institute on Drug Abuse Proteomics Center at Yale University), and UL1-RR-024139 (Yale Clinical and Translational Science Award) from the National Institutes of Health (NIH); and by the State of Connecticut, Department of Mental Health and Addiction Services. T.D.M.-B. was supported by NIH Grant T32-MH-014276. M.J.M. and S.R.G. were supported by NIH Grants DA-003194 and DA-015663. J.M.L. was supported by NIH Grant NS-11323.
Funding
National Institute on Drug Abuse
DA14241National Institute of Mental Health
MH077681National Institute of Mental Health
MH092681National Institute on Drug Abuse
DA018343National Center for Research Resources
RR024139National Institute of Mental Health
MH014276National Institute on Drug Abuse
DA003194National Institute on Drug Abuse
DA015663National Institute of Neurological Disorders and Stroke
NS11323
Other Version
- You are viewing the most recent version of this article.
- previous version (August 03, 2016).
Article usage
In this issue
